《JAMA,2月5日,2019 Novel Coronavirus-Important Information for Clinicians》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-06
  • 2019 Novel Coronavirus—Important Information for Clinicians

    Carlos del Rio, MD; Preeti N. Malani, MD, MSJ

    JAMA. Published online February 5, 2020. doi:10.1001/jama.2020.1490

    In early December 2019 a patient was diagnosed with an unusual pneumonia in the city of Wuhan, China. By December 31 the World Health Organization (WHO) regional office in Beijing had received notification of a cluster of patients with pneumonia of unknown cause from the same city.1 Wuhan, the capital city of Hubei Province in central China, is the nation’s seventh largest city, with a population of 11 million people. Over the next few days, researchers at the Wuhan Institute of Virology performed metagenomics analysis using next-generation sequencing from a sample collected from a bronchoalveolar lavage and identified a novel coronavirus as the potential etiology. They called it novel coronavirus 2019 (nCoV-2019).2 The US Centers for Disease Control and Prevention (CDC) refers to it as 2019 novel coronavirus (2019-nCoV).

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2760782
相关报告
  • 《JAMA,6月1日,Mental Health of Young Physicians in China During the Novel Coronavirus Disease 2019 Outbreak》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-02
    • Mental Health of Young Physicians in China During the Novel Coronavirus Disease 2019 Outbreak Weidong Li, MD, PhD1; Elena Frank, PhD2; Zhuo Zhao, MS2; et al Lihong Chen, PhD1,2,3; Zhen Wang, MD4; Margit Burmeister, PhD2,5; Srijan Sen, MD, PhD2,5 Author Affiliations Article Information JAMA Netw Open. 2020;3(6):e2010705. doi:10.1001/jamanetworkopen.2020.10705 Introduction With more than 3 million cases worldwide, the novel coronavirus disease 2019 (COVID-19) poses a growing global public health challenge.1 Medical personnel disproportionately bear the additional physical and psychological burdens associated with pandemics, yet the mental health implications of COVID-19 for physicians are unknown.2,3 In this cohort study, we assessed anxiety, depression, mood, and other established factors associated with mental health problems in a cohort of young physicians in China before and during the outbreak. Methods The ethics committees of Shanghai Jiao Tong University and the University of Michigan approved this study. All participants provided written informed consent and were compensated ¥25 (as of May 7, 2020, ¥1 = $0.14 US). This study follows the American Association for Public Opinion Research (AAPOR) reporting guideline.
  • 《JAMA,3月9日,Diagnostic Testing for the Novel Coronavirus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-11
    • Diagnostic Testing for the Novel Coronavirus Joshua M. Sharfstein, MD1; Scott J. Becker, MS2; Michelle M. Mello, JD, PhD3 Author Affiliations Article Information JAMA. Published online March 9, 2020. doi:10.1001/jama.2020.3864 Controversies over diagnostic testing have dominated US headlines about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic. The CDC also initially limited access to testing to a narrow group of individuals with known exposure. The delayed discovery of a case of COVID-19 in California, followed quickly by evidence of community transmission in multiple states, revealed the shortcomings of this strategy. In the early stages, COVID-19 has spread beyond the nation’s ability to detect it.